Goldman Sachs Asset Management has closed its West Street Life Sciences I fund, raising $650 million, surpassing its target. The fund, which is the first in the firm's Life Sciences Investing strategy, will focus on growth-oriented private equity investments in early to mid-stage therapeutic companies, life sciences tools, and diagnostics companies. It has already committed approximately $90 million across five portfolio companies. Goldman Sachs Asset Management oversees more than $2.6 trillion in assets as of September 30, 2023. GS shares saw a slight increase of 0.32% in premarket trading.